February 15 2011 Issue

February 15 2011 Issue

1) Motor cortex inhibition and 2) Topic of the month: Neurotoxins. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interviews Dr. Don Gilbert about his paper on motor cortex inhibition. In the next segment, Dr. Stacey Clardy is reading our e-Pearl of the week about ictal asystole. In the next part of the podcast Dr. Beau Bruce interviews Dr. Jonathan Rutchik about neurolgic effects of organic solvents for our Lesson of the Week. Next week, we will discuss ciguatera poisoning. The participants had nothing to disclose except Drs. Gilbert, Clardy and Bruce.Dr. Gilbert has received honoraria from the Tourette Syndrome Association/ Centers for Disease Control, the Movement Disorder Society, the American Academy of Neurology, and the American Academy of Pediatrics; serves on the medical advisory board for the Tourette Syndrome Association; writes board review questions for PREP SA (American Academy of Pediatrics); has received research support from the NIH [NIMH R01 MH078160, NIMH R01 MH08185, and NINDS NS056276], and from Cincinnati Children's Hospital Research Foundation, the University of Cincinnati, and the Tourette Syndrome Association.Dr. Clardy serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Bruce has received grant funding from the AAN/AANF Practice Research Fellowship and is funded by NIH grants UL1-RR025008 and KL2-RR025009.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1367)

When Drug Marketing Masquerades as Clinical Trials

When Drug Marketing Masquerades as Clinical Trials

Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care.  Read the relat...

13 Jul 17min

Neurology® at 75: The Evolution of the Neurology Journal

Neurology® at 75: The Evolution of the Neurology Journal

To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®.  Read more about the first ...

9 Jul 30min

Navigating the Transition From Pediatric to Adult Epilepsy Care

Navigating the Transition From Pediatric to Adult Epilepsy Care

Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care.  Read the related article in Neurology® Clinical Practice.   Disclosures can be found a...

6 Jul 22min

Communication About Uncertainty During PD Diagnostic Consultations

Communication About Uncertainty During PD Diagnostic Consultations

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.  Read the rel...

2 Jul 16min

July 2026 Recall: Updates in Epilepsy

July 2026 Recall: Updates in Epilepsy

The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medic...

1 Jul 1h 8min

Comparing Sensitivity of Nerve Biopsy, Skin Biopsy, and Fat Aspirate in ATTRv-PN

Comparing Sensitivity of Nerve Biopsy, Skin Biopsy, and Fat Aspirate in ATTRv-PN

Dr. Katie Krulisky talks with Dr. Marcus Pinto about the diagnosis and management of hereditary ATTR amyloidosis.  Read the related article in Neurology®.  Disclosures can be found at Neurology.org.

29 Jun 28min

2026 European Stroke Organization Conference

2026 European Stroke Organization Conference

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent research presented at the 2026 European Stroke Organization Conference.  Read more about TAPIS trial.  Read more about the ODEA-TIA ...

25 Jun 25min

Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD

Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD

Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy.  Read more about this abstra...

22 Jun 12min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
sinnsyn
rekommandert
tomprat-med-gunnar-tjomlid
liberal-halvtime
villmarksliv
dekodet-2
fjellsportpodden
vett-og-vitenskap-med-gaute-einevoll
abid-nadia-skyld-og-skam
smart-forklart
rss-rekommandert
rss-paradigmepodden
rss-inn-til-kjernen-med-sunniva-rose
tidlose-historier
rss-bondevennen
rss-nysgjerrige-norge